Executive Summary
VA awarded $245.6M in healthcare & services contracts, signaling robust demand for medical evaluations ($94M fully executed), utilities ($84M obligated, $0 outlayed), and training ($67M with $55M outlayed). High execution rates in VES (100%) and Victor 12 (81%) highlight reliable revenue for service providers, while ConEd's unexercised $116M options offer upside.
Investors should prioritize VA-aligned firms with strong execution track records amid firm-fixed-price structures.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior VA Healthcare & Services Contracts digest from February 25, 2026.
Investment Signals (2)
- Strong VA execution in medical & training services (HIGH)▲
VES achieved 100% outlay on $94M MDE contract; Victor 12 hit 81% ($55M/$67M) on training BPA, demonstrating revenue reliability.
- $116M unexercised options in VA utilities (MEDIUM)▲
ConEd's $84M obligation has $116M potential upside to $200M total via options, in non-competitive structure favoring incumbents.
Risk Flags (2)
- Execution [HIGH RISK]▼
Firm-fixed-price terms across all contracts expose providers to cost overruns; ConEd shows $0 outlay after 3+ years.
- Competitive [MEDIUM RISK]▼
Short-term (VES 1-year ended 2023) and task-order dependent (Victor 12 BPA) structures risk non-renewal without follow-ons.
Opportunities (2)
- ◆
Follow-on potential post-full execution: VES $94M track record in open MDE competition; Victor 12 veteran-owned alignment for extensions to 2027.
- ◆
ConEd $116M unexercised options in non-competitive utilities, plus Victor 12's $17M remaining ceiling.
Sector Themes (2)
- ◆
100% of contracts are firm-fixed-price under full/open competition (2/3) or non-competitive (1/3), blending medical evals, training, and utilities.
- ◆
High outlays in services (avg 90% for VES/Victor 12) contrast with 0% for utilities, amid varying durations (1yr to 5yr).
Watch List (3)
- 👁
{"entity"=>"Veterans Evaluation Services, Inc.", "reason"=>"Full $94M execution positions for MDE follow-ons in open competition.", "trigger"=>"New VA 36C10X solicitations >$50M"}
- 👁
{"entity"=>"Consolidated Edison Company of New York, Inc.", "reason"=>"$116M options unexercised after 3+ years; non-competitive edge.", "trigger"=>"Any outlay >$10M or option exercises"}
- 👁
{"entity"=>"Victor 12, Inc.", "reason"=>"81% outlay as SDVOSB in training; $17M ceiling + 2027 extension potential.", "trigger"=>"BPA calls exceeding $70M total"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 3 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: VA Healthcare & Services Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
US Pre-Market SEC Filings Roundup — May 26, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
Biotech Small-Cap Approvals — May 26, 2026
Biotech Small-Cap Approvals
May 26, 2026
Big Pharma Approvals — May 26, 2026
Big Pharma Approvals